Luspatercept May Prolong Life in Low-Risk MDS ...Middle East

Medscape - News
Luspatercept May Prolong Life in Low-Risk MDS
Updated, longer-term results from the COMMANDS trial show a promising trend toward improved overall survival with luspatercept vs epoetin alfa, in addition to transfusion independence benefits. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Luspatercept May Prolong Life in Low-Risk MDS )

Also on site :